Premium Nahrungsergänzungsmittel | artgerecht

Growth Hormone Provocation Test – Definition & Procedure

The growth hormone provocation test is a diagnostic procedure used to assess the pituitary gland´s ability to secrete growth hormone. It is performed when growth hormone deficiency is suspected.

Regular tips about health Regular tips about health

Things worth knowing about "Growth Hormone Provocation Test"

The growth hormone provocation test is a diagnostic procedure used to assess the pituitary gland´s ability to secrete growth hormone. It is performed when growth hormone deficiency is suspected.

What Is the Growth Hormone Provocation Test?

The growth hormone provocation test (also called the growth hormone stimulation test) is a specialized endocrinological diagnostic procedure. It is used to assess the ability of the pituitary gland to release sufficient amounts of growth hormone (somatotropin, GH). Because GH is secreted in pulses and circulates at very low and variable baseline levels, a single resting blood measurement is not reliable for diagnosis. Instead, the test uses specific stimuli to challenge the pituitary gland and measure its maximum secretory capacity.

When Is the Test Performed?

The test is used in both children and adults when growth hormone deficiency (GHD) is suspected. Common indications include:

Growth retardation or short stature in children
Delayed puberty
Suspected hypopituitarism (underactivity of the pituitary gland)
Evaluation following head trauma, brain tumor, or radiation to the pituitary region
Adults with symptoms of GH deficiency (e.g., increased body fat, reduced muscle mass, fatigue)

How Is the Test Performed?

The growth hormone provocation test is conducted under strict medical supervision, usually in a hospital or specialized outpatient clinic. The patient arrives in a fasted state. Various stimulating agents can be used to trigger GH secretion:

Insulin Tolerance Test (ITT): Considered the gold standard. Insulin is administered to induce controlled hypoglycemia (low blood sugar), which is a potent stimulus for GH release. Close monitoring is required throughout.
Arginine test: Intravenous infusion of the amino acid arginine, which stimulates GH secretion.
Glucagon test: Injection of glucagon, a hormone that also stimulates the pituitary gland.
GHRH + Arginine test: A combination of growth hormone-releasing hormone (GHRH) and arginine, commonly used in adults.
Clonidine test: Administration of the alpha-2 agonist clonidine, particularly used in children.

During the test, blood samples are collected at regular intervals (e.g., every 15 to 30 minutes over 2 to 3 hours) to measure serum GH levels.

Interpretation of Results

Results are evaluated based on the peak GH value reached during the test:

In children, a peak GH below 10 ng/mL (depending on the laboratory and assay used) is generally considered indicative of GH deficiency.
In adults, the cutoff value varies between 3 and 11 ng/mL depending on the test used.
A sufficient GH rise argues against a clinically relevant deficiency.

Since no single test provides absolute certainty, at least two different provocation tests are typically required in children to confirm the diagnosis.

Preparation and Safety

Preparation usually involves fasting for several hours before the test. Factors such as obesity, hypothyroidism, pubertal status, and certain medications can affect GH responses and must be taken into account when interpreting results. The insulin tolerance test is contraindicated in patients with epilepsy, coronary artery disease, or severe hypopituitarism without adequate cortisol reserve. All tests are performed under direct medical supervision with emergency support available.

Clinical Significance

The growth hormone provocation test is an essential component of endocrinological diagnostics. A confirmed diagnosis of GH deficiency is a prerequisite for initiating growth hormone replacement therapy with recombinant human somatotropin, which can promote growth in children and improve quality of life, body composition, and metabolism in adults.

References

Mullis P. E. et al. - Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence. European Journal of Endocrinology, 2001.
Growth Hormone Research Society - Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II. European Journal of Endocrinology, 2007.
Ranke M. B., Wit J. M. - Growth hormone - past, present and future. Nature Reviews Endocrinology, 2018.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.